http://orcid.org/0000-0003-1096-7306
References
- Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2017;67(1):7–30.
- Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–1614.
- Saftlas AF, Hoover RN, Brinton LA, et al. Mammographic densities and risk of breast cancer. Cancer. 1991;67(11):2833–2838.
- Tsilidis KK, Kasimis JC, Lopez DS, et al. Type 2 diabetes and cancer: umbrella review of metaanalyses of observational studies. BMJ. 2015;350(jan02 1):g7607–g7607.
- American Diabetes Association. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes. Diabetes Care. 2018;2018(1):41–85.
- Song CW, Lee H, Dings RP, et al. Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep. 2012;2(1):362.
- D’Orsi CJ, Sickles EA, Mendelson EB, eds, et al. American College of Radiology: American College of Radiology breast imaging reporting and data system BI-RADS. 5th ed. Reston (VA): American College of Radiology; 2013.
- Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674–1685.
- Wu JW, Azoulay L, Majdan A, et al. Long-term use of long-acting insulin analogs and breast cancer incidence in women with type 2 diabetes. J Clin Oncol. 2017;35(32):3647–3653.
- Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. Am J Epidemiol. 2000;152(10):950–964.
- Ritte R, Lukanova A, Tjønneland A, et al. Height, age at menarche and risk of hormone receptorpositive and -negative breast cancer: a cohort study. Int J Cancer. 2013;132(11):2619–2629.
- Heckman-Stoddard BM, DeCensi A, Sahasrabuddhe VV, et al. Metformin for the prevention of cancer and cancer recurrence. Diabetoligia. 2017;60 (9):1639–1647.
- Bershteĭn LM, Vasil'ev DA, Kovalenko IG, et al. The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women. Vopr Onkol. 2012;58(1):45–49.